Knowledge and Compliance of Oral Anticoagulation Therapy at Warfarin Clinic in Kathmandu: A Cross-sectional Study
Keywords:
Anticoagulant, Knowledge, Nepal, Patient compliance, WarfarinAbstract
Background: Warfarin is the most widely used anticoagulant drug worldwide due to its low cost and ease of use. Adequate knowledge and compliance to oral anticoagulation therapy are essential measures that decrease morbidity and mortality among cardiac patients. This study aimed to assess the level of knowledge and compliance regarding oral anticoagulation therapy among patients with a mechanical heart valve.
Methods: A cross-sectional study was carried out among patients with mechanical heart valves on warfarin at Shahid Gangalal National Heart Centre of Kathmandu, Nepal. Participants were selected through a systematic random sampling technique, and a face-to-face interview was conducted. Knowledge was assessed using validated oral anticoagulation knowledge questionnaires composed of 20 multiple-choice questions. Compliance was assessed using 8 items Morisky Medication Adherence Scale. The descriptive and bivariate analysis were carried out using the Statistical Package for the Social Sciences version 16.
Results: A total of 222 patients were included in this study. Only 35 (15.8%) had good knowledge, and 93 (41.9%) had high compliance to oral anticoagulation therapy. The mean adherence score was 1.81 ± 0.78. Age, literacy, and educational level of the patients were statistically significant with knowledge. The compliance was significantly related only with a duration of warfarin use (p=0.003).
Conclusion: The patients had a moderate level of knowledge on warfarin therapy. However, they had good compliance with oral anticoagulation therapy. Based on the findings, education awareness program is recommended to improve the patient’s knowledge on oral anticoagulants.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Roji Shakya, Muna Maharjan, Sabita Karki, Takma K.C.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/